Compounds > aripiprazole

Page last updated: 2024-08-24

aripiprazole and oxcarbazepine

aripiprazole has been researched along with oxcarbazepine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Murphy, TK; Negin, B	1
Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM	1
de Leon, J; Loveland, JG; McGrane, IR	1

Reviews

1 review(s) available for aripiprazole and oxcarbazepine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for aripiprazole and oxcarbazepine

Article	Year
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Priapism associated with oxcarbazepine, aripiprazole, and lithium. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:12 Topics: Adolescent; Affective Symptoms; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Child; Child Development Disorders, Pervasive; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Oxcarbazepine; Penile Erection; Piperazines; Priapism; Quinolones	2005
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study. Journal of affective disorders, 2010, Volume: 121, Issue:1-2 Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid	2010
Possible Oxcarbazepine Inductive Effects on Aripiprazole Metabolism: A Case Report. Journal of pharmacy practice, 2018, Volume: 31, Issue:3 Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Carbamazepine; Child; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Male; Oxcarbazepine; Treatment Outcome	2018